Skip to content
TrialScanner

NCT05348200

Safety and Efficacy of CITI-002 in Adult Patients With Moderate Grade Hemorrhoids

Phase 2CompletedCTXRLead

Registry record

Lead sponsor
Citius Pharmaceuticals, Inc.
Conditions
Hemorrhoids
Primary completion
Apr 20, 2023Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT05348200 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.